Figure 4.
Less exhausted-like effector T-cell immunophenotype is associated with greater immunotoxicity in patients treated with nivolumab–R-CHOP.

Less exhausted-like effector T-cell immunophenotype is associated with greater immunotoxicity in patients treated with nivolumab–R-CHOP.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal